JW and JZ Modifiers: Drug Waste Documentation for Medicare These two modifiers apply to the J-code line, not to CPT 96372
Therefore, a KLOW dosage guide developed for young, healthy models might not be appropriate for older or immunocompromised subjects, requiring careful adjustments
Combining two GLP-1 pathway medications provides no additional benefit and significantly increases the risk of side effects, including severe nausea, vomiting, and hypoglycemia
Avoid stacking with other direct lipolytic compounds without professional guidance
It is also available from some private clinics
Who Should Exercise Extra Caution or Avoid Retatrutide Patients with a history of medullary thyroid carcinoma, MEN2, pancreatitis, severe gastroparesis, or pregnancy should exercise particular caution or avoid retatrutide until further safety data are available